No Data
No Data
Express News | Quoin Pharmaceuticals Shares Resume Trade
Express News | Quoin Pharmaceuticals Shares Halted On Circuit Breaker To The Upside, Stock Now Up 70%
Quoin Pharmaceuticals at Risk of Nasdaq Delisting Amidst Financial Challenges
Quoin Pharmaceuticals | 8-K: Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2024 Financial Results
Maxim Group Maintains Quoin Pharmaceuticals(QNRX.US) With Buy Rating, Maintains Target Price $2
Promising Developments and Financial Stability Propel Quoin Pharmaceuticals' Buy Rating
No Data